FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2935667229> ?p ?o ?g. }

• W2935667229 endingPage "209" @default.
• W2935667229 startingPage "203" @default.
• W2935667229 abstract "Abstract Background Long-term treatment is recommended in major depressive disorder (MDD) to prevent relapse and to restore functioning. The aim of this study (Orion; NCT01360866) was to assess the long-term safety, tolerability, and efficacy of open-label treatment with adjunctive brexpiprazole in adult patients with MDD. Methods Patients rolled over into this 52-week study (amended to 26 weeks) from 3 randomized, double-blind, placebo-controlled studies. Patients received brexpiprazole 0.5 to 3 mg/d (flexible dose) adjunct to their current antidepressant treatment. The primary outcome variable was the frequency and severity of treatment-emergent adverse events (TEAEs). Efficacy was assessed as a secondary objective using clinical rating scales. Results A total of 2944 patients were enrolled (1547 for 52 weeks, 1397 for 26 weeks), of whom 1895 (64.4%) completed the study. The TEAEs with incidence of 5% or greater were weight increase (17.7%), somnolence (8.0%), headache (7.2%), akathisia (6.7%), increased appetite (6.3%), insomnia (6.3%), fatigue (6.1%), viral upper respiratory tract infection (5.4%), and anxiety (5.2%). Most TEAEs were mild or moderate in severity. The mean increase in body weight was 2.7 kg to week 26 and 3.2 kg to week 52; 25.8% of patients had a weight increase of 7% or greater at any postbaseline visit. There were no clinically relevant findings related to extrapyramidal symptoms, prolactin, lipids, or glucose. Patients’ symptoms and functioning showed continual improvement. Conclusions Adjunctive treatment with open-label brexpiprazole 0.5 to 3 mg/d was generally well tolerated for up to 52 weeks in patients with MDD and was associated with continued improvement in efficacy measures and functional outcomes." @default.
• W2935667229 created "2019-04-11" @default.
• W2935667229 creator A5005720083 @default.
• W2935667229 creator A5021739236 @default.
• W2935667229 creator A5023091059 @default.
• W2935667229 creator A5029547645 @default.
• W2935667229 creator A5033150501 @default.
• W2935667229 creator A5045081626 @default.
• W2935667229 creator A5056479433 @default.
• W2935667229 date "2019-05-01" @default.
• W2935667229 modified "2023-10-16" @default.
• W2935667229 title "A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder" @default.
• W2935667229 cites W1868790909 @default.
• W2935667229 cites W1923219172 @default.
• W2935667229 cites W1929751478 @default.
• W2935667229 cites W1979604894 @default.
• W2935667229 cites W1993810702 @default.
• W2935667229 cites W1998648170 @default.
• W2935667229 cites W1999689270 @default.
• W2935667229 cites W2000053835 @default.
• W2935667229 cites W2021696580 @default.
• W2935667229 cites W2035804130 @default.
• W2935667229 cites W2043075431 @default.
• W2935667229 cites W2046186483 @default.
• W2935667229 cites W2049571898 @default.
• W2935667229 cites W2054507400 @default.
• W2935667229 cites W2074874853 @default.
• W2935667229 cites W2084779737 @default.
• W2935667229 cites W2131823335 @default.
• W2935667229 cites W2138437831 @default.
• W2935667229 cites W2140725933 @default.
• W2935667229 cites W2148083007 @default.
• W2935667229 cites W2151839057 @default.
• W2935667229 cites W2162630389 @default.
• W2935667229 cites W2165379748 @default.
• W2935667229 cites W2171672882 @default.
• W2935667229 cites W2340538438 @default.
• W2935667229 cites W2562628019 @default.
• W2935667229 cites W2751884637 @default.
• W2935667229 cites W2777439954 @default.
• W2935667229 cites W2789214860 @default.
• W2935667229 cites W2803445534 @default.
• W2935667229 cites W2902154350 @default.
• W2935667229 cites W2925768352 @default.
• W2935667229 cites W4232352194 @default.
• W2935667229 doi "https://doi.org/10.1097/jcp.0000000000001034" @default.
• W2935667229 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6494030" @default.
• W2935667229 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30946704" @default.
• W2935667229 hasPublicationYear "2019" @default.
• W2935667229 type Work @default.
• W2935667229 sameAs 2935667229 @default.
• W2935667229 citedByCount "14" @default.
• W2935667229 countsByYear W29356672292019 @default.
• W2935667229 countsByYear W29356672292020 @default.
• W2935667229 countsByYear W29356672292021 @default.
• W2935667229 countsByYear W29356672292022 @default.
• W2935667229 countsByYear W29356672292023 @default.
• W2935667229 crossrefType "journal-article" @default.
• W2935667229 hasAuthorship W2935667229A5005720083 @default.
• W2935667229 hasAuthorship W2935667229A5021739236 @default.
• W2935667229 hasAuthorship W2935667229A5023091059 @default.
• W2935667229 hasAuthorship W2935667229A5029547645 @default.
• W2935667229 hasAuthorship W2935667229A5033150501 @default.
• W2935667229 hasAuthorship W2935667229A5045081626 @default.
• W2935667229 hasAuthorship W2935667229A5056479433 @default.
• W2935667229 hasBestOaLocation W29356672291 @default.
• W2935667229 hasConcept C118552586 @default.
• W2935667229 hasConcept C126322002 @default.
• W2935667229 hasConcept C142724271 @default.
• W2935667229 hasConcept C197934379 @default.
• W2935667229 hasConcept C204787440 @default.
• W2935667229 hasConcept C27081682 @default.
• W2935667229 hasConcept C2776412080 @default.
• W2935667229 hasConcept C2777393122 @default.
• W2935667229 hasConcept C2778375690 @default.
• W2935667229 hasConcept C2779034229 @default.
• W2935667229 hasConcept C2779144063 @default.
• W2935667229 hasConcept C2780051608 @default.
• W2935667229 hasConcept C2780494398 @default.
• W2935667229 hasConcept C2780580376 @default.
• W2935667229 hasConcept C2780616385 @default.
• W2935667229 hasConcept C3018162438 @default.
• W2935667229 hasConcept C42219234 @default.
• W2935667229 hasConcept C71924100 @default.
• W2935667229 hasConceptScore W2935667229C118552586 @default.
• W2935667229 hasConceptScore W2935667229C126322002 @default.
• W2935667229 hasConceptScore W2935667229C142724271 @default.
• W2935667229 hasConceptScore W2935667229C197934379 @default.
• W2935667229 hasConceptScore W2935667229C204787440 @default.
• W2935667229 hasConceptScore W2935667229C27081682 @default.
• W2935667229 hasConceptScore W2935667229C2776412080 @default.
• W2935667229 hasConceptScore W2935667229C2777393122 @default.
• W2935667229 hasConceptScore W2935667229C2778375690 @default.
• W2935667229 hasConceptScore W2935667229C2779034229 @default.
• W2935667229 hasConceptScore W2935667229C2779144063 @default.
• W2935667229 hasConceptScore W2935667229C2780051608 @default.
• W2935667229 hasConceptScore W2935667229C2780494398 @default.
• W2935667229 hasConceptScore W2935667229C2780580376 @default.

• next